24575113|t|Association between the COMTVal158Met Genotype and Alzheimer's Disease in the Han Chinese Population.
24575113|a|BACKGROUND: Alzheimer's disease (AD) is the leading cause of dementia worldwide and is associated with individual, familial and social burdens. Catechol-O-methyltransferase (COMT) may have a prominent role in AD pathophysiology by affecting the metabolism of catecholamine neurotransmitters and estrogen. Although the COMT rs4680 gene polymorphism has been investigated as a susceptibility factor for AD, the results are inconsistent. The aim of this study was to examine the influence of the COMT rs4680 gene polymorphism as a risk factor for AD in the Han Chinese population and its synergistic effect with the apolipoprotein E (APOE)gene. METHODS: A total of 137 AD patients and 194 healthy controls were analyzed. Clinical criteria and neuropsychological tests were used to establish diagnostic groups. All subjects were analyzed for the COMTrs4680 polymorphism and APOEgenotype. RESULTS: No significant differences were observed between AD and control subjects regarding the COMT genotype frequencies of Val/Val, Val/Met and Met/Met, but Met alleles were higher in AD than in control subjects (35.4 and 28.1%, p = 0.045). A minor synergistic effect between the genotypes GG and APOEepsilon4 was observed in AD patients (OR: 5.707, 95% CI: 2.505-13.002, p < 0.001). This synergistic effect was greater in women, who showed higher OR of AD (16.007, 95% CI: 4.606-56.118, p < 0.001) versus the AD group with APOE epsilon4 (11.972, 95% CI: 5.534-25.902, p < 0.001). Furthermore, the COMT Met allele was an independent risk factor for AD without APOE epsilon4 allele carriers (OR: 1.806, 95% CI: 1.160-2.810, p = 0.009), especially in men (OR: 4.904, 95% CI: 2.381-10.099, p < 0.001). CONCLUSION: The COMT(Val158Met) polymorphism is not an independent risk factor for AD but shows a synergistic effect between the genotypes GG and APOEepsilon4 that proves greater in women with AD. The COMT Met allele represents a risk factor in AD without APOE epsilon4 allele carriers, which is notable in men with AD.
24575113	51	70	Alzheimer's Disease	Disease	MESH:D000544
24575113	114	133	Alzheimer's disease	Disease	MESH:D000544
24575113	135	137	AD	Disease	MESH:D000544
24575113	163	171	dementia	Disease	MESH:D003704
24575113	246	274	Catechol-O-methyltransferase	Gene	1312
24575113	276	280	COMT	Gene	1312
24575113	311	313	AD	Disease	MESH:D000544
24575113	361	392	catecholamine neurotransmitters	Chemical	-
24575113	420	424	COMT	Gene	1312
24575113	425	431	rs4680	SNP	tmVar:rs4680;VariantGroup:0;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606
24575113	503	505	AD	Disease	MESH:D000544
24575113	595	599	COMT	Gene	1312
24575113	600	606	rs4680	SNP	tmVar:rs4680;VariantGroup:0;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606
24575113	646	648	AD	Disease	MESH:D000544
24575113	715	731	apolipoprotein E	Gene	348
24575113	733	737	APOE	Gene	348
24575113	768	770	AD	Disease	MESH:D000544
24575113	771	779	patients	Species	9606
24575113	1044	1046	AD	Disease	MESH:D000544
24575113	1082	1086	COMT	Gene	1312
24575113	1111	1118	Val/Val	ProteinMutation	tmVar:p|SUB|V||V;VariantGroup:2;CorrespondingGene:1312;CorrespondingSpecies:9606
24575113	1120	1127	Val/Met	ProteinMutation	tmVar:p|SUB|V||M;VariantGroup:1;CorrespondingGene:1312;CorrespondingSpecies:9606
24575113	1132	1139	Met/Met	ProteinMutation	tmVar:p|SUB|M||M;VariantGroup:3;CorrespondingGene:1312;CorrespondingSpecies:9606
24575113	1172	1174	AD	Disease	MESH:D000544
24575113	1314	1316	AD	Disease	MESH:D000544
24575113	1317	1325	patients	Species	9606
24575113	1411	1416	women	Species	9606
24575113	1442	1444	AD	Disease	MESH:D000544
24575113	1498	1500	AD	Disease	MESH:D000544
24575113	1512	1516	APOE	Gene	348
24575113	1586	1590	COMT	Gene	1312
24575113	1637	1639	AD	Disease	MESH:D000544
24575113	1648	1652	APOE	Gene	348
24575113	1737	1740	men	Species	9606
24575113	1803	1807	COMT	Gene	1312
24575113	1808	1817	Val158Met	ProteinMutation	tmVar:p|SUB|V|158|M;HGVS:p.V158M;VariantGroup:0;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606;CA#:127287
24575113	1870	1872	AD	Disease	MESH:D000544
24575113	1969	1974	women	Species	9606
24575113	1980	1982	AD	Disease	MESH:D000544
24575113	1988	1992	COMT	Gene	1312
24575113	2032	2034	AD	Disease	MESH:D000544
24575113	2043	2047	APOE	Gene	348
24575113	2094	2097	men	Species	9606
24575113	2103	2105	AD	Disease	MESH:D000544
24575113	Positive_Correlation	MESH:D000544	RS#:4680;CorrespondingGene:1312
24575113	Association	MESH:D000544	RS#:4680;HGVS:p.V158M;CorrespondingGene:1312
24575113	Positive_Correlation	MESH:D000544	CorrespondingGene:1312;CorrespondingSpecies:9606;VariantGroup:3;tmVar:p
24575113	Positive_Correlation	MESH:D000544	CorrespondingGene:1312;CorrespondingSpecies:9606;VariantGroup:1;tmVar:p
24575113	Positive_Correlation	MESH:D000544	RS#:4680;CorrespondingGene:1312
24575113	Association	MESH:D000544	1312
24575113	Association	MESH:D000544	1312

